These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 21460676)

  • 21. Satisfying patient expectations with soft-tissue augmentation.
    Mandy SH
    Dermatol Online J; 2009 Jul; 15(7):1. PubMed ID: 19903429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A decade of experience with injectable poly-L-lactic acid: a focus on safety.
    Bartus C; William Hanke C; Daro-Kaftan E
    Dermatol Surg; 2013 May; 39(5):698-705. PubMed ID: 23379657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The "skinny"on Sculptra: a practical primer to volumization with poly-L-lactic acid.
    Palm M; Chayavichitsilp P
    J Drugs Dermatol; 2012 Sep; 11(9):1046-52. PubMed ID: 23135646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Poly-L-lactic acid.
    Perry CM
    Am J Clin Dermatol; 2004; 5(5):361-6; discussion 367-8. PubMed ID: 15554738
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Injectable poly-L-lactic acid for human immunodeficiency virus-associated facial lipoatrophy: cumulative year 2 interim analysis of an open-label study (FACES).
    Bassichis B; Blick G; Conant M; Condoluci D; Echavez M; Eviatar J; Gold MH; Hamilton T; Hanke CW; Humble G; LaMarca A; Daro-Kaftan E; Mest D; Pierone G
    Dermatol Surg; 2012 Jul; 38(7 Pt 2):1193-205. PubMed ID: 22759256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ArteFill: a long-lasting injectable wrinkle filler material--summary of the U.S. Food and Drug Administration trials and a progress report on 4- to 5-year outcomes.
    Cohen SR; Berner CF; Busso M; Gleason MC; Hamilton D; Holmes RE; Romano JJ; Rullan PP; Thaler MP; Ubogy Z; Vecchione TR
    Plast Reconstr Surg; 2006 Sep; 118(3 Suppl):64S-76S. PubMed ID: 16936546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and efficacy of poly-L-lactic acid injections in persons with HIV-associated lipoatrophy: the US experience.
    Mest DR; Humble G
    Dermatol Surg; 2006 Nov; 32(11):1336-45. PubMed ID: 17083585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Poly-L-lactic acid: a new dimension in soft tissue augmentation.
    Rotunda AM; Narins RS
    Dermatol Ther; 2006; 19(3):151-8. PubMed ID: 16784514
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Facial volumetric correction with injectable poly-L-lactic acid.
    Vleggaar D
    Dermatol Surg; 2005 Nov; 31(11 Pt 2):1511-7; discussion 1517-8. PubMed ID: 16416633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Objective Analysis of Poly-L-Lactic Acid Injection Efficacy in Different Settings.
    Byun SY; Seo KI; Shin JW; Kwon SH; Park MS; Lee J; Park KC; Na JI; Huh CH
    Dermatol Surg; 2015 Dec; 41 Suppl 1():S314-20. PubMed ID: 26618458
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The history behind the use of injectable poly-L-lactic acid for facial and nonfacial volumization: the positive impact of evolving methodology.
    Vleggaar D; Fitzgerald R; Lorenc ZP
    J Drugs Dermatol; 2014 Apr; 13(4 Suppl):s32-4. PubMed ID: 24719075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The need for consensus recommendations on the use of injectable poly-L-lactic acid for facial and nonfacial volumization.
    Vleggaar D; Fitzgerald R; Lorenc ZP
    J Drugs Dermatol; 2014 Apr; 13(4 Suppl):s28. PubMed ID: 24719073
    [No Abstract]   [Full Text] [Related]  

  • 33. Autologous fat grafting and injectable dermal fillers for human immunodeficiency virus-associated facial lipodystrophy: a comparison of safety, efficacy, and long-term treatment outcomes.
    Shuck J; Iorio ML; Hung R; Davison SP
    Plast Reconstr Surg; 2013 Mar; 131(3):499-506. PubMed ID: 23142937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The safety and efficacy of poly-L-lactic acid on sunken cheeks in Asians.
    Suh DH; Lee SJ; Kim SM; Lee JD; Kim HS
    J Cosmet Laser Ther; 2014 Aug; 16(4):180-4. PubMed ID: 24684570
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Persistent granulomatous inflammatory response induced by injectable poly-L-lactic acid for HIV lipoatrophy.
    Wildemore JK; Jones DH
    Dermatol Surg; 2006 Nov; 32(11):1407-9; discussion 1409. PubMed ID: 17083596
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment of the aged hand with injectable poly-l-lactic acid.
    Rendon MI; Cardona LM; Pinzon-Plazas M
    J Cosmet Laser Ther; 2010 Dec; 12(6):284-7. PubMed ID: 21142738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Soft tissue augmentation using sculptra.
    Humble G; Mest D
    Facial Plast Surg; 2004 May; 20(2):157-63. PubMed ID: 15643584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cosmetic use of poly-l-lactic acid: a retrospective study of 130 patients.
    Palm MD; Woodhall KE; Butterwick KJ; Goldman MP
    Dermatol Surg; 2010 Feb; 36(2):161-70. PubMed ID: 20039924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness of Juvéderm Ultra Plus dermal filler in the treatment of severe nasolabial folds.
    Lupo MP; Smith SR; Thomas JA; Murphy DK; Beddingfield FC
    Plast Reconstr Surg; 2008 Jan; 121(1):289-297. PubMed ID: 18176233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Poly-L-lactic acid: a perspective from my practice.
    Sadick NS
    J Cosmet Dermatol; 2008 Mar; 7(1):55-60. PubMed ID: 18254813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.